Vaxart Inc Stock Market Value
VXRT Stock | USD 0.60 0.01 1.64% |
Symbol | Vaxart |
Vaxart Inc Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.40) | Revenue Per Share 0.085 | Quarterly Revenue Growth 3.714 | Return On Assets (0.40) | Return On Equity (0.92) |
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxart is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vaxart 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaxart's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaxart.
10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Vaxart on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Vaxart Inc or generate 0.0% return on investment in Vaxart over 30 days. Vaxart is related to or competes with Inovio Pharmaceuticals, Ibio, Co Diagnostics, Novavax, and Ocugen. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant prote... More
Vaxart Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaxart's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaxart Inc upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.19) | |||
Maximum Drawdown | 20.06 | |||
Value At Risk | (7.37) | |||
Potential Upside | 4.88 |
Vaxart Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxart's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaxart's standard deviation. In reality, there are many statistical measures that can use Vaxart historical prices to predict the future Vaxart's volatility.Risk Adjusted Performance | (0.11) | |||
Jensen Alpha | (0.67) | |||
Total Risk Alpha | (1.15) | |||
Treynor Ratio | (0.70) |
Vaxart Inc Backtested Returns
Vaxart Inc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16% return per unit of risk over the last 3 months. Vaxart Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaxart's Variance of 13.35, risk adjusted performance of (0.11), and Coefficient Of Variation of (649.98) to confirm the risk estimate we provide. The entity has a beta of 0.82, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vaxart's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vaxart is expected to be smaller as well. At this point, Vaxart Inc has a negative expected return of -0.55%. Please make sure to validate Vaxart's skewness and day typical price , to decide if Vaxart Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.74 |
Good predictability
Vaxart Inc has good predictability. Overlapping area represents the amount of predictability between Vaxart time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaxart Inc price movement. The serial correlation of 0.74 indicates that around 74.0% of current Vaxart price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.74 | |
Spearman Rank Test | 0.75 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Vaxart Inc lagged returns against current returns
Autocorrelation, which is Vaxart stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vaxart's stock expected returns. We can calculate the autocorrelation of Vaxart returns to help us make a trade decision. For example, suppose you find that Vaxart has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Vaxart regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vaxart stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vaxart stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vaxart stock over time.
Current vs Lagged Prices |
Timeline |
Vaxart Lagged Returns
When evaluating Vaxart's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vaxart stock have on its future price. Vaxart autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vaxart autocorrelation shows the relationship between Vaxart stock current value and its past values and can show if there is a momentum factor associated with investing in Vaxart Inc.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.